Advanced Cardiac Therapeutics

Advanced Cardiac Therapeutics

Advanced Cardiac Therapeutics, Inc. is a pre-commercial, medical device company that designs and manufactures a catheter-based system for the treatment of patients with atrial fibrillation.

Related Articles & Links

March 28, 2016 Advanced Cardiac Therapeutics Successfully Completes Clinical Trial Enrollment

March 25, 2016 Duke Rohlen, Spirox & Advanced Cardiac Therapeutics

January 25, 2016 Advanced Cardiac Therapeutics Completes Successful First in Man

October 29, 2014 Abbott Labs to Buy Private Medical Device Company Topera

April 24, 2014 Advanced Cardiac Therapeutics Completes Equity Financing Round

May 7, 2012 Advanced Cardiac Therapeutics Announces Several Key Appointments

Our Philosophy

We focus on portfolio returns, big opportunities, high-quality team, and financials that demonstrate a deep understanding of the business. We look for companies where our experience and expertise can add value to produce better outcomes for both entrepreneurs and our investments.

Our Networks

Relationships and people matter. Over the decades, we have developed personal relationships with other quality investors (both Angels and VCs), service providers, and domain experts. If we do not know the answer, we know someone who does.

Our Mentorship

When the company wins, we all win. To maximize success, we often serve as advisors or board members. Both art and science are involved in building a supportive and useful board as well as maintaining solid investor relations. Good financial discipline lays the foundation for success and informs company strategy.

Our Strategy

We like healthcare, especially digital health, but also diagnostics, devices, and bio/genomics. For funding, we often co-invest with other investors and are happy to lead investment rounds. We know term sheets and what drives syndicated investment rounds.
Scroll to top